Serum metabolomics related to chimeric antigen receptor (car) t-cell therapy

Abstract

Disclosed herein are methods and compositions for determining and improving the likelihood of response and/or determining and decreasing the likelihood of toxicity to a cellular therapy using metabolomics. Embodiments of the disclosure include methods for measuring certain metabolites in …